Testing effectiveness (Phase 2)Study completedNCT00343083
What this trial is testing
Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442)
Who this might be right for
Cancer of Head and Neck
University of Maryland, Baltimore 43